Consider a complex tissue like the brain or a tumor. Traditional methods might tell us which genes are active, but they lose the crucial 'where.' This is where spatial technologies change the game. At STOmics, we work at this intersection of location and function. Two terms often arise in this field: spatial genomics and spatial transcriptomics. While interconnected, their technological scope and the biological questions they answer differ in meaningful ways. We will clarify these distinctions and explore how they fit within the broader vision of spatial biology.

Defining the Genomic and Transcriptomic Layers

To grasp the difference, we start with what each technology measures. Spatial genomics focuses on the DNA blueprint within a cell in its native tissue context. It aims to map genomic features—like gene copies, mutations, or structural variations—and tie them to a specific location. This can reveal how genetic heterogeneity is spatially organized within a sample. In contrast, spatial transcriptomics measures the RNA output, the transcriptome. It shows which genes are actively being expressed into messenger RNA (mRNA) in each spot. This provides a functional snapshot, revealing active biological processes and cell states precisely where they occur. While spatial transcriptomics has seen rapid adoption for profiling gene expression, spatial genomics investigates the underlying genetic architecture that may dictate those expression patterns.

The Unifying Field of Spatial Biology

Both approaches are foundational pillars of the larger field of spatial biology. The goal of spatial biology is not just to catalog molecules, but to understand the complex, coordinated interactions that define life at the tissue level. By preserving spatial information, we move from seeing a tissue as a 'soup' of cells to appreciating it as an architectural masterpiece with specialized neighborhoods. Spatial genomics and spatial transcriptomics each contribute a unique layer to this map. One reveals the static, inherited code and its local variations, while the other illuminates the dynamic, functional activity reading that code. Together, they provide a more complete picture of cellular identity and tissue organization.

Integrated Applications and Analytical Power

The true potential is realized when these layers are integrated. For instance, in cancer research, spatial genomics could identify a cluster of cells with a specific driver mutation. Spatial transcriptomics could then show that this same cluster exhibits a gene expression signature associated with drug resistance or metastatic potential. This correlation of genotype and phenotype in situ is powerful. At STOmics, our Stereo-seq technology is designed for this integration. By enabling high-plex, high-resolution co-profiling of the genome and transcriptome from the same tissue section, we allow researchers to connect genetic variation with its functional transcriptional consequences directly on the tissue map, pushing the boundaries of what spatial biology can achieve.

In summary, spatial genomics and spatial transcriptomics offer complementary scopes. One maps the inherited DNA landscape, and the other charts the active RNA output, both within the essential context of space. They are not competing technologies but synergistic tools within spatial biology. For researchers asking complex questions about tissue organization, disease mechanisms, or development, understanding this distinction is the first step. At STOmics, we provide the integrated tools and platforms that empower scientists to explore both the genomic and transcriptomic dimensions of spatial biology within a single, coherent experimental framework.